跳至主要内容
临床试验/TCTR20160216002
TCTR20160216002已完成2 期

The study of the effectiveness of silver nanoparticle for the treatment of acne vulgaris

Faculty of Medicine, Srinakharinwirot University0 个研究点目标入组 64 人开始时间: 2016年2月16日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • The patients aged over 18 years old with moderate acne vulgaris by the Leeds-revised criteria with voluntarily signed with informed consent

排除标准

  • 1. Patients who previously applied topical corticosteroids, silver-containing drug, topical erythromycin, topical clindamycin, benzoyl peroxide, topical retinoids, chemical peels, topical vitamin C and E within two weeks prior to the study
  • 2. Patients who took oral supplementation (oral zinc, vitamin C, vitamin E), oral antibiotics, oral corticosteroids within six weeks prior to study and oral retinoids within six months prior to study
  • 3. Patients who were allergic to silver-containing drug, benzoyl peroxide and topical clindamycin
  • 4. Currently pregnant and lactating women
  • 5. Active skin lesion on study site
  • 6. Unable to follow-up according to the study protocol

研究者

发起方
Faculty of Medicine, Srinakharinwirot University

相似试验